SCHEMBL7923429

SCHEMBL7923429

C/C=C(/Cc1ccccc1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.66
CYP2C9 P11712 1/20 0.66
CES1 P23141 2/20 0.54
CES2 O00748 1/20 0.54
AKR1B1 P15121 1/20 0.54
CTBP2 P56545 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
TSHR P16473 2/20 0.46
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 1/20 0.44
EPHX2 P34913 1/20 0.44
GAA P10253 2/20 0.43
HPGD P15428 1/20 0.43
PAM P19021 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367454 1.00 CYP3A4 (0.66) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL265774 1.00 CYP3A4 (0.66) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL10073601 0.83 CTBP2 (0.55) CYP3A4CYP2C9CTBP2MEN1KMT2A
SCHEMBL27840697 0.83 CYP3A4 (0.52) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL4740992 0.83 CYP3A4 (0.52) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL4740994 0.83 CYP3A4 (0.52) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL21081470 0.83 CYP3A4 (0.52) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL8921169 0.83 CYP3A4 (0.66) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL11401347 0.83 CYP3A4 (0.66) CYP3A4CYP2C9CES1CES2AKR1B1
SCHEMBL7336694 0.82 CYP3A4 (0.59) CYP3A4CYP2C9CES1CES2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10316080-B2 Protein-polymer-drug conjugates ASANA BIOSCIENCES, LLC (US) 2019-06-11 US disclosed
US-6191184-B1 SUITABLE FOR FORMATION OF LIQUID CRYSTAL DISPLAY (LCD) SPACERS OR PROTECTIVE LAYERS; PHOTOSETTING PROPERTIES ADHESIVENESS TO SUBSTRATES; MECHANICAL CHARACTERISTICS, STORAGE STABILITY SHOW EXCELLENT WORKING FUJI PHOTO FILM CO., LTD. (JP) 2001-02-20 US disclosed
US-6048852-A BACTERICIDES SMITHKLINE BEECHAM P.L.C. (GB) 2000-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10316080-B2 Protein-polymer-drug conjugates PBRM1, STAMBP, TSPO CYP3A4 3343/4885CYP2C9 3394/4885CES1 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.